Thapsigargin and its prodrug derivatives: exploring novel approaches for targeted cancer therapy through calcium signaling disruption. - Khurram I; Khan MU; Ibrahim S; Ghani MU; Amin I; Falzone L; Herrera-Bravo J; Setzer WN; Sharifi-Rad J; Calina D (Medical oncology (Northwood, London, England), 2024)